Brighthouse [BHF] vs MetLife [MET] Detailed Stock Comparison
Brighthouse
NASDAQ
Loading...
MetLife
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Brighthouse wins in 11 metrics, MetLife wins in 6 metrics, with 0 ties. Brighthouse appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Brighthouse | MetLife | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 5.27 | 13.37 | Brighthouse |
| Price-to-Book Ratio | 0.46 | 1.90 | Brighthouse |
| Debt-to-Equity Ratio | 160.02 | 171.72 | Brighthouse |
| PEG Ratio | 0.01 | -0.70 | MetLife |
| EV/EBITDA | N/A | 9.58 | N/A |
| Profit Margin (TTM) | 8.24% | 5.87% | Brighthouse |
| Operating Margin (TTM) | 14.15% | 5.61% | Brighthouse |
| EBITDA Margin (TTM) | 14.15% | 5.61% | Brighthouse |
| Return on Equity | 13.46% | 15.51% | MetLife |
| Return on Assets (TTM) | 0.65% | 0.59% | Brighthouse |
| Free Cash Flow (TTM) | $-290.00M | $14.60B | MetLife |
| Dividend Yield | N/A | 2.10% | N/A |
| 1-Year Return | 3.81% | 6.59% | MetLife |
| Price-to-Sales Ratio (TTM) | 0.33 | 0.72 | Brighthouse |
| Enterprise Value | $4.36B | $69.42B | MetLife |
| EV/Revenue Ratio | 0.54 | 0.95 | Brighthouse |
| Revenue per Share (TTM) | $137 | $106 | Brighthouse |
| Earnings per Share (Diluted) | $8.75 | $5.89 | Brighthouse |
| Beta (Stock Volatility) | 0.88 | 0.83 | MetLife |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Brighthouse vs MetLife Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Brighthouse | 1.44% | 3.09% | -6.70% | -19.87% | -20.78% | -1.88% |
| MetLife | 2.84% | 1.69% | 3.81% | 1.72% | -2.18% | -3.11% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Brighthouse | 3.81% | -2.79% | 48.11% | -31.66% | -31.66% | -31.66% |
| MetLife | 6.59% | 20.65% | 101.01% | 76.68% | 135.06% | 81.87% |
Performance & Financial Health Analysis: Brighthouse vs MetLife
| Metric | BHF | MET |
|---|---|---|
| Market Information | ||
| Market Cap | $2.64B | $52.35B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 692,303 | 3,570,695 |
| 90 Day Avg. Volume | 851,361 | 3,222,868 |
| Last Close | $47.09 | $81.49 |
| 52 Week Range | $40.00 - $64.12 | $65.21 - $89.05 |
| % from 52W High | -26.56% | -8.49% |
| All-Time High | $75.00 (Jul 17, 2017) | $89.05 (Nov 25, 2024) |
| % from All-Time High | -37.21% | -8.49% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.39% | -0.03% |
| Quarterly Earnings Growth | 1.50% | -0.23% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.06% |
| Operating Margin (TTM) | 0.14% | 0.06% |
| Return on Equity (TTM) | 0.13% | 0.16% |
| Debt to Equity (MRQ) | 160.02 | 171.72 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $99.31 | $41.52 |
| Cash per Share (MRQ) | $131.16 | $45.83 |
| Operating Cash Flow (TTM) | $51.00M | $15.23B |
| Levered Free Cash Flow (TTM) | $-1,421,500,032 | $2.87B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.10% |
| Last 12-Month Dividend | N/A | $1.65 |
Valuation & Enterprise Metrics Analysis: Brighthouse vs MetLife
| Metric | BHF | MET |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 5.27 | 13.37 |
| Forward P/E | 2.31 | 8.12 |
| PEG Ratio | 0.01 | -0.70 |
| Price to Sales (TTM) | 0.33 | 0.72 |
| Price to Book (MRQ) | 0.46 | 1.90 |
| Market Capitalization | ||
| Market Capitalization | $2.64B | $52.35B |
| Enterprise Value | $4.36B | $69.42B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.54 | 0.95 |
| Enterprise to EBITDA | N/A | 9.58 |
| Risk & Other Metrics | ||
| Beta | 0.88 | 0.83 |
| Book Value per Share (MRQ) | $99.31 | $41.52 |
Financial Statements Comparison: Brighthouse vs MetLife
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BHF | MET |
|---|---|---|
| Revenue/Sales | $790.00M | $17.16B |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | $93.00M | $980.00M |
| Income Tax | $8.00M | $245.00M |
| Net Income (Profit) | $85.00M | $735.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BHF | MET |
|---|---|---|
| Cash & Equivalents | $4.67B | $21.33B |
| Total Current Assets | N/A | N/A |
| Total Current Liabilities | N/A | N/A |
| Long-Term Debt | $3.16B | $18.85B |
| Total Shareholders Equity | $5.30B | $27.76B |
| Retained Earnings | $-1.39B | $43.13B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BHF | MET |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $146.00M | $4.26B |
| Debt Repayment | N/A | $-810.00M |
| Common Stock Repurchase | $-59.00M | $-1.41B |
Short Interest & Institutional Ownership Analysis
| Metric | BHF | MET |
|---|---|---|
| Shares Short | 2.57M | 7.44M |
| Short Ratio | 2.76 | 2.67 |
| Short % of Float | 0.06% | 0.01% |
| Average Daily Volume (10 Day) | 692,303 | 3,570,695 |
| Average Daily Volume (90 Day) | 851,361 | 3,222,868 |
| Shares Outstanding | 58.63M | 689.21M |
| Float Shares | 56.45M | 554.69M |
| % Held by Insiders | 0.01% | 0.00% |
| % Held by Institutions | 0.87% | 0.92% |
Dividend Analysis & Yield Comparison: Brighthouse vs MetLife
| Metric | BHF | MET |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.65 |
| Last 12-Month Dividend Yield | N/A | 2.10% |
| 3-Year Avg Annual Dividend | N/A | $1.93 |
| 3-Year Avg Dividend Yield | N/A | 0.77% |
| 3-Year Total Dividends | N/A | $5.78 |
| Ex-Dividend Date | N/A | Feb 04, 2025 |